Research Topic

Functional Characterization and Pharmaceutical Targets in Common and Rare CFTR Dysfunctions

About this Research Topic

There have been major breakthroughs in the treatment of people with cystic fibrosis (CF) in recent years, largely due to the development of highly effective Cystic fibrosis transmembrane conductance regulator (CFTR) gene modulators. Underpinning the discovery of these modulator drugs have led to greater understanding of the structure and function of CFTR and how CFTR dysfunction can lead to the development of infection and inflammation in the airways, as well as issues at other organ sites. However, further scientific research is required in order to address many of the unsolved issues that remain in CF including rare mutations or alternative ways to restore CFTR function.

In considering the future of cystic fibrosis (CF) care, this Research Topic focuses on five key areas, which are discussed in this report: the changing epidemiology of cystic fibrosis; future challenges of clinical care and its delivery; identifying molecular targets and underlying physiology; and the discovery of emerging therapeutics.

1. Understanding the structure and function of CFTR
2. Functional characterization of CFTR rare mutations
3. Evaluation of how CFTR dysfunction can lead to the development of gut and lung infection and inflammation
4. Novel CFTR compounds, alternate ways to restore CFTR function and new pharmacological targets to control CF
5. Consequences of novel CFTR modulator therapies for inflammatory responses and mucus rheology in the lung and in the gut
6. Drug repositioning approaches towards CF inflammation and infection
7. Contribution to advances using different animal models of CF, as well as organoids


Keywords: cystic fibrosis, respiratory dysfunction, pharmacological targets, functional characterization, CFTR


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

There have been major breakthroughs in the treatment of people with cystic fibrosis (CF) in recent years, largely due to the development of highly effective Cystic fibrosis transmembrane conductance regulator (CFTR) gene modulators. Underpinning the discovery of these modulator drugs have led to greater understanding of the structure and function of CFTR and how CFTR dysfunction can lead to the development of infection and inflammation in the airways, as well as issues at other organ sites. However, further scientific research is required in order to address many of the unsolved issues that remain in CF including rare mutations or alternative ways to restore CFTR function.

In considering the future of cystic fibrosis (CF) care, this Research Topic focuses on five key areas, which are discussed in this report: the changing epidemiology of cystic fibrosis; future challenges of clinical care and its delivery; identifying molecular targets and underlying physiology; and the discovery of emerging therapeutics.

1. Understanding the structure and function of CFTR
2. Functional characterization of CFTR rare mutations
3. Evaluation of how CFTR dysfunction can lead to the development of gut and lung infection and inflammation
4. Novel CFTR compounds, alternate ways to restore CFTR function and new pharmacological targets to control CF
5. Consequences of novel CFTR modulator therapies for inflammatory responses and mucus rheology in the lung and in the gut
6. Drug repositioning approaches towards CF inflammation and infection
7. Contribution to advances using different animal models of CF, as well as organoids


Keywords: cystic fibrosis, respiratory dysfunction, pharmacological targets, functional characterization, CFTR


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

31 October 2020 Abstract
09 January 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

31 October 2020 Abstract
09 January 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..